4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Cartesian Therapeutics, Inc. (RNAC) operates in the Biotechnology industry and is headquartered in Frederick, United States with about 75 employees. Its market capitalization is roughly $240 million. In the fiscal year ended 2025-12-31, RNAC reported $3M in revenue and ($130M) in net income.
Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases.
Interactive charts & full statements → Open the RNAC valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $3M | $39M | $26M | $111M | — |
| Operating Income (EBIT) | ($87M) | ($36M) | ($86M) | $14M | — |
| Net Income | ($130M) | ($77M) | ($220M) | $35M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $1M | $0M | $0M | $1M | — |
| Operating Income (EBIT) | ($26M) | ($22M) | ($21M) | ($22M) | ($22M) | — |
| Net Income | ($39M) | ($93M) | ($36M) | $16M | ($18M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $296M | $435M | $305M | $166M | — |
| Total Liabilities | $423M | $442M | $745M | $72M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive RNAC viewer.
About TickerBase · Data methodology & sources